Prognostic Factors in Patients After Chemotherapy for Germ Cell Tumors
Author Information
Author(s): Fosså S D, Stenning S P, Gerl A, Horwich A, Clark P I, Wilkinson P M, Jones W G, Williams M V, Oliver R T, Newlands E S, Mead G M, Cullen M H, Kaye S B, Rustin G J S, Cook P A
Primary Institution: Department of Medical Oncology and Radiotherapy, The Norwegian Radium Hospital, Montebello, Oslo, Norway
Hypothesis
What are the prognostic parameters for survival in patients with malignant germ cell tumors progressing after platinum-based chemotherapy?
Conclusion
The study identified key prognostic factors that can predict survival in patients with malignant germ cell tumors after chemotherapy.
Supporting Evidence
- The 5-year survival rate for all progressing patients was 30%.
- Patients with a progression-free interval of >2 years had a 5-year survival of 61%.
- None of the patients in the poor prognosis group survived after 3 years.
Takeaway
Doctors can use certain signs to tell if patients with testicular cancer will do well after treatment. If they have bad signs, they might not survive long.
Methodology
The study analyzed 164 patients who progressed after chemotherapy and validated prognostic factors in an independent data set of 66 patients.
Participant Demographics
83% testicular and 17% extragonadal germ cell tumors.
Statistical Information
Confidence Interval
95% confidence interval 23–38%
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website